Cargando…

Atlanta metropolitan area amyotrophic lateral sclerosis (ALS) surveillance: incidence and prevalence 2009–2011 and survival characteristics through 2015

Amyotrophic lateral sclerosis (ALS) is a fatal, rare, and hard to diagnose neurological disease with unknown etiology. OBJECTIVE: To understand the incidence, prevalence, and survival characteristics of ALS cases in the Atlanta metropolitan area. METHODS: Neurologists in Clayton, Cobb, DeKalb, Fulto...

Descripción completa

Detalles Bibliográficos
Autores principales: PUNJANI, RESHMA, WAGNER, LAURIE, HORTON, KEVIN, KAYE, WENDY
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130365/
https://www.ncbi.nlm.nih.gov/pubmed/31795746
http://dx.doi.org/10.1080/21678421.2019.1682614
_version_ 1783694509170753536
author PUNJANI, RESHMA
WAGNER, LAURIE
HORTON, KEVIN
KAYE, WENDY
author_facet PUNJANI, RESHMA
WAGNER, LAURIE
HORTON, KEVIN
KAYE, WENDY
author_sort PUNJANI, RESHMA
collection PubMed
description Amyotrophic lateral sclerosis (ALS) is a fatal, rare, and hard to diagnose neurological disease with unknown etiology. OBJECTIVE: To understand the incidence, prevalence, and survival characteristics of ALS cases in the Atlanta metropolitan area. METHODS: Neurologists in Clayton, Cobb, DeKalb, Fulton, and Gwinnett counties provided case reports for ALS patients under their care from 1 January 2009 to 31 December 2011. Incidence and prevalence rates were calculated for 2009, 2010, and 2011 by sex, race, and ethnicity. Using data from the National Death Index, survival time was calculated for age, sex, race, ethnicity, and El Escorial criteria. RESULTS: There were 281 unique ALS cases reported, which is approximately 104% of the expected cases. The majority of the 281 cases were white, non-Hispanic, male, and in the 50–59 age category. The overall average incidence rate for 2009 to 2011 was 1.54 per 100,000 person-years, with higher annual incidence rates for whites, males, and non-Hispanics. The prevalence rates for 2009, 2010, and 2011 were 5.05, 5.44, and 5.56 per 100,000, respectively. Median survival time was highest for the 18–39 age group, Asians, non-Hispanics, and males. Additionally, the log-rank tests for homogeneity across strata indicate a statistical significance between strata for the age category for survival time. CONCLUSION: The findings for Atlanta are similar to other population-based studies in the United States. Although the Atlanta metropolitan area was selected to over-represent the minority population, the strongest predictor of survival time was age at diagnosis.
format Online
Article
Text
id pubmed-8130365
institution National Center for Biotechnology Information
language English
publishDate 2019
record_format MEDLINE/PubMed
spelling pubmed-81303652021-05-18 Atlanta metropolitan area amyotrophic lateral sclerosis (ALS) surveillance: incidence and prevalence 2009–2011 and survival characteristics through 2015 PUNJANI, RESHMA WAGNER, LAURIE HORTON, KEVIN KAYE, WENDY Amyotroph Lateral Scler Frontotemporal Degener Article Amyotrophic lateral sclerosis (ALS) is a fatal, rare, and hard to diagnose neurological disease with unknown etiology. OBJECTIVE: To understand the incidence, prevalence, and survival characteristics of ALS cases in the Atlanta metropolitan area. METHODS: Neurologists in Clayton, Cobb, DeKalb, Fulton, and Gwinnett counties provided case reports for ALS patients under their care from 1 January 2009 to 31 December 2011. Incidence and prevalence rates were calculated for 2009, 2010, and 2011 by sex, race, and ethnicity. Using data from the National Death Index, survival time was calculated for age, sex, race, ethnicity, and El Escorial criteria. RESULTS: There were 281 unique ALS cases reported, which is approximately 104% of the expected cases. The majority of the 281 cases were white, non-Hispanic, male, and in the 50–59 age category. The overall average incidence rate for 2009 to 2011 was 1.54 per 100,000 person-years, with higher annual incidence rates for whites, males, and non-Hispanics. The prevalence rates for 2009, 2010, and 2011 were 5.05, 5.44, and 5.56 per 100,000, respectively. Median survival time was highest for the 18–39 age group, Asians, non-Hispanics, and males. Additionally, the log-rank tests for homogeneity across strata indicate a statistical significance between strata for the age category for survival time. CONCLUSION: The findings for Atlanta are similar to other population-based studies in the United States. Although the Atlanta metropolitan area was selected to over-represent the minority population, the strongest predictor of survival time was age at diagnosis. 2019-12-04 2020-02 /pmc/articles/PMC8130365/ /pubmed/31795746 http://dx.doi.org/10.1080/21678421.2019.1682614 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Article
PUNJANI, RESHMA
WAGNER, LAURIE
HORTON, KEVIN
KAYE, WENDY
Atlanta metropolitan area amyotrophic lateral sclerosis (ALS) surveillance: incidence and prevalence 2009–2011 and survival characteristics through 2015
title Atlanta metropolitan area amyotrophic lateral sclerosis (ALS) surveillance: incidence and prevalence 2009–2011 and survival characteristics through 2015
title_full Atlanta metropolitan area amyotrophic lateral sclerosis (ALS) surveillance: incidence and prevalence 2009–2011 and survival characteristics through 2015
title_fullStr Atlanta metropolitan area amyotrophic lateral sclerosis (ALS) surveillance: incidence and prevalence 2009–2011 and survival characteristics through 2015
title_full_unstemmed Atlanta metropolitan area amyotrophic lateral sclerosis (ALS) surveillance: incidence and prevalence 2009–2011 and survival characteristics through 2015
title_short Atlanta metropolitan area amyotrophic lateral sclerosis (ALS) surveillance: incidence and prevalence 2009–2011 and survival characteristics through 2015
title_sort atlanta metropolitan area amyotrophic lateral sclerosis (als) surveillance: incidence and prevalence 2009–2011 and survival characteristics through 2015
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130365/
https://www.ncbi.nlm.nih.gov/pubmed/31795746
http://dx.doi.org/10.1080/21678421.2019.1682614
work_keys_str_mv AT punjanireshma atlantametropolitanareaamyotrophiclateralsclerosisalssurveillanceincidenceandprevalence20092011andsurvivalcharacteristicsthrough2015
AT wagnerlaurie atlantametropolitanareaamyotrophiclateralsclerosisalssurveillanceincidenceandprevalence20092011andsurvivalcharacteristicsthrough2015
AT hortonkevin atlantametropolitanareaamyotrophiclateralsclerosisalssurveillanceincidenceandprevalence20092011andsurvivalcharacteristicsthrough2015
AT kayewendy atlantametropolitanareaamyotrophiclateralsclerosisalssurveillanceincidenceandprevalence20092011andsurvivalcharacteristicsthrough2015